Factors Influencing on Correctness of Inhalation Technique.
- Conditions
- COPDAsthma
- Interventions
- Other: Assessment of correctness of inhaling technique
- Registration Number
- NCT04203446
- Lead Sponsor
- Medical University of Warsaw
- Brief Summary
Asthma and COPD are common chronic diseases of respiratory system. The correct use of inhalers is crucial in terms of efficacy of the treatment, however both asthma and COPD patients quite frequently misuse the inhalers. The objective of this study is to determine the factors influencing the number of inhalation errors committed by asthma and COPD patients when using the inhalers.
In included patients the inhalation technique will be evaluated (by both list of inhalation errors and 4 point scale of proper inhaling) by two observers and the below information will be collected:
* general demographic information and education level
* information concerning time of diagnosis, the previous course of disease, smoking history, number of previous inhalation techniques training, the sources of information about the inhalation technique and adherence to therapy
* Asthma Control Test or COPD Assessment Test (respectively for asthma and COPD)
* assessment of quality of life (St. George's Questionnaire for COPD and Asthma Quality of Life Questionnaire for asthma)
* cognitive functions assessment using Mini-Mental State Examination
* the simplified assessment of vision impairments
* the results of spirometry
- Detailed Description
Asthma and chronic obstructive pulmonary disease (COPD) are common chronic diseases of respiratory system. Asthma affects about 5% of adults in Poland. The inhaling therapy is the cornerstone of asthma treatment, especially inhaled glucocorticosteroids (ICS). The correct use of inhalers is crucial for efficiency of the therapy and reduction of undesirable side effects of medications. COPD is also a common chronic respiratory disease that affects about 10% of adults above 40 years old. The most important action to prevent and to treat COPD is to stop smoking. The main medications used by COPD patients are inhaled bronchodilators. Both asthma and COPD patients misuse the inhalers.
The objective of this study is to determine the factors influencing the number of inhalation errors committed by asthma and COPD patients when using the inhalers.
Patients:
Patients with asthma or COPD treated in hospital or in out-patient clinic will be asked for participating in the study. Power analysis and sample size calculations indicated that a sample size of 215 subjects (with either asthma or COPD) would provide statistical power to detect even weak correlation (r=0.2) assuming error alpha = 0.05, beta = 0.20 and 10% drop out.
Study design
In included patients inhalation technique will be evaluated (by both list of inhalation errors and 4 point scale of proper inhaling) by two observers and the below information will be gathered:
* general demographic information and education level
* information concerning time of diagnosis, the previous course of disease, smoking history, number of previous inhalation techniques training, the sources of information about the inhalation technique and adherence to therapy
* Asthma Control Test and COPD Assessment Test respectively for asthma and COPD
* assessment of quality of life with the disease (St. George's Questionnaire for COPD and Asthma Quality of Life Questionnaire for asthma)
* cognitive functions assessment using Mini-Mental State Examination
* the simplified assessment of vision impairments
* the results of spirometry The main outcome will be correlation between inhalation technique and other above mentioned factors.
Identification of factors influencing the inhaling errors in patients with asthma or COPD will enable to plan the actions to improve the efficiency of inhaler medications use. At the end of the study all patients will be taught how to use their inhalers properly.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 180
- Informed consent for participating in the study
- Age 18 -85 years
- COPD or asthma diagnosed at least 3 months prior to enrolment
- using of at least one inhaler regularly every day
- using one of the inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI) or Metered Dose Liquid Inhalers (MDLI)
- Lack of informed consent
- Age <18 years or > 85 years old
- Diagnosis of asthma or COPD shorter than 3 months before enrollment
- Using inhalers unregularly.
- Symptoms of infection 5 days prior to beginning of the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Adults with asthma or COPD Assessment of correctness of inhaling technique Adults (18-85 years old) with asthma or COPD diagnosed at least 3 months earlier, who are regularly treated with at least one inhlaer daily
- Primary Outcome Measures
Name Time Method Assessment of correctness of inhalation technique baseline Assessment of correctness of inhalation technique by list of inhalation errors and 4 point scale of proper inhaling and by two observers
- Secondary Outcome Measures
Name Time Method Assessment of vision impairments baseline assessment of vision impairments by Snellen vision test boards
Assessment of asthma or COPD duration baseline asthma or COPD duration
Assessment of quality of life related to asthma baseline Asthma Quality of Life Questionnaire score for asthma
Assessment of general demographic features baseline smoking history (pack/years)
Assessment of earlier training in inhalation technique baseline number of earlier trainings in inhalation technique
Assessment of educational level baseline educational level (basic, secondary, higher)
Assessment of quality of life related to COPD baseline St. George's Questionnaire score for COPD
Assesment of basic cognitive function baseline Mini-Mental State Examination score
Assessment of patient's adherence baseline number of days with missed doses of inhaled drugs per month
Assessment of asthma or COPD severity baseline Asthma Control Test score or COPD Assessment Test score respectively for asthma and COPD
Trial Locations
- Locations (1)
Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw
🇵🇱Warsaw, Poland